Crossmedika Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CROSSMEDIKA SA, and what generic and branded alternatives to CROSSMEDIKA SA drugs are available?
CROSSMEDIKA SA has five approved drugs.
Summary for Crossmedika Sa
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Crossmedika Sa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crossmedika Sa | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 209057-004 | Oct 31, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Crossmedika Sa | MOXIFLOXACIN HYDROCHLORIDE | moxifloxacin hydrochloride | TABLET;ORAL | 205348-001 | Jan 14, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Crossmedika Sa | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 209057-003 | Oct 31, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Crossmedika Sa | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 213500-001 | Jul 22, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Crossmedika Sa | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 211116-002 | May 20, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Crossmedika Sa | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 213500-003 | Jul 22, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
